End Cash: The amount of cash held by the company for the given period.
Bluejay Diagnostics, Inc. (BJDX) had End Cash of $4.30M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-20.94M |
|
-- |
|
-- |
|
$7.17M |
|
$-7.17M |
|
$-0.55M |
|
$-7.72M |
|
$-7.72M |
|
$-7.72M |
|
$-7.72M |
|
$-7.72M |
|
$-7.72M |
|
$-7.17M |
|
$-6.97M |
|
0.05M |
|
0.05M |
|
$-456.76 |
|
$-456.76 |
|
| Balance Sheet Financials | |
$4.90M |
|
$1.51M |
|
$1.76M |
|
$6.66M |
|
$0.81M |
|
-- |
|
$0.12M |
|
$0.93M |
|
$5.73M |
|
$5.73M |
|
$5.73M |
|
0.14M |
|
| Cash Flow Statement Financials | |
$-7.82M |
|
$-0.31M |
|
$10.22M |
|
$2.21M |
|
|
End Cash |
$4.30M |
$2.09M |
|
$0.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.13M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-134.70% |
|
-134.70% |
|
-115.93% |
|
-134.70% |
|
$41.37 |
|
$-177.25 |
|
$-170.56 |
|